Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UCSF Receives $2 Million to Advance UC-Wide Biobanking Initiative

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Goal of the project is to develop an ethical, efficient and sustainable system for obtaining, processing and sharing biospecimens and data.

UCSF's Clinical and Translational Science Institute (CTSI) has been awarded $2 million to advance a biobanking project involving the five University of California campuses.

The goal of the project, Engaging University of California Stakeholders for Biorepository Research (EngageUC), is to develop an ethical, efficient and sustainable system for obtaining, processing and sharing biospecimens and data.

It includes outpatient facilities at the UC medical center campuses - Davis, Irvine, Los Angeles, San Diego and San Francisco.

This award by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), is a supplement to the five-year, $112 million renewal award (grant number UL1 TR000004) that UCSF’s CTSI received as part of the Clinical and Translational Science Award program in 2011.

“This is a very important project,” said Clay Johnston, MD, PhD, associate vice chancellor of research and director of CTSI at UCSF.

Johnston continued, “Not only does it deal with a critical issue about appropriate consent for biospecimens, a problem we’re much better able to address together, but it also builds on relationships across the UCs that we’ve been bridging more and more successfully recently through efforts such as UC BRAID.”

Johnston is also co-principal investigator with Steven Dubinett, MD, associate vice chancellor for research and director of the Clinical and Translational Science Institute at UCLA.

The three-year project includes four main components:

• Facilitating coordination among UC institutional officials and Institutional Review Boards (IRBs);
• Developing harmonized procedures among UC biorepository researchers and leaders;
• Undertaking a randomized control trial to determine optimal methods for obtaining informed consent from patients; and
• Educating California's diverse communities to provide engaged input and feedback on UC's biorepository studies.

EngageUC is co-directed by Elizabeth Boyd, PhD, associate vice chancellor of Ethics and Compliance, program director of CTSI’s Regulatory Knowledge and Support Program and associate adjunct professor of Social and Behavioral Science at UCSF; Sarah Dry, MD, associate professor in the UCLA David Geffen School of Medicine; and Daniel Dohan, PhD, associate professor of Health Policy and Social Medicine and associate director of the Philip R. Lee Institute for Health Policy Studies at UCSF.

John Wilbanks, an expert on portable legal consent issues, is serving as a consultant on the project.

“This research will address one of the most pressing challenges facing bioethics - how best to inform participants about the research that may be conducted with their donated, discarded tissue,” Boyd said. “It will also allow us to develop best practices for the University of California.”

According to Dohan, EngageUC is particularly exciting because it is bringing together stakeholders - from researchers and leaders at UC to a diverse group of Californians from across the state - to determine how biobanking can be an effective tool for improving health.

EngageUC is also being informed by the Biobanking Initiative of UC BRAID, an existing consortium of the UC medical campuses focused on advancing clinical and translational research.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Newborn Gut Microbiome Predicts Later Allergy and Asthma
Microbial byproducts link particular early-life gut microbes to immune dysfunction.
Wednesday, September 14, 2016
NASA's DNA Sequencing in Space is a Success
DNA has been sequenced in space for the first time ever for the Biomolecule Sequencer investigation, using the MinION sequencing device.
Wednesday, August 31, 2016
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Friday, August 26, 2016
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
All patients with high levels of one immune-cell type responded to treatment.
Tuesday, August 16, 2016
Gene Variant Explains Differences in Diabetes Drug Response
International precision medicine study advances understanding of the biology of Metformin.
Thursday, August 11, 2016
Go-Between Immune Cell is Key to Priming the Body’s Fight Against Cancer
‘Antigen-presenting cell’ activates T cells by alerting them to the presence of tumors.
Friday, July 15, 2016
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Friday, June 24, 2016
Tarantula Toxins Offer Key Insights Into Neuroscience of Pain
Toxins extracted from ornamental baboon tarantula may be used as tools to study disorders ranging from irritable bowel syndrome to epilepsy.
Tuesday, June 07, 2016
Cirrhosis-Causing Cells Converted to Healthy Liver Cells in Mice
New approach that repairs liver from within may be more efficient than cell transplants.
Friday, June 03, 2016
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Friday, May 27, 2016
Immune System Implicated in Gastroschisis
UCSF researchers show that the immune system is implicated in gastroschisis. The findings could lead to improved treatments for the belly birth defect.
Tuesday, May 17, 2016
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
Tuesday, April 26, 2016
Tense Tumours Lead to Poorer Prognosis
UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.
Tuesday, April 19, 2016
Gene Behind Rare Childhood Syndrome Identified
Online activism by one patient’s mother spurred research collaboration which led to the identification of a new genetic syndrome.
Friday, April 15, 2016
UCSF Immunologist to Head New Parker Institute for Cancer Immunotherapy
Renowned UC San Francisco immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation.
Thursday, April 14, 2016
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Atmosphere Acidity Minimised to Preindustrial Levels
Sheet ice study shows acidic pollution of the atmosphere has now almost returned to preindustrial levels.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Potential of New Insect Control Traits in Agriculture
Researchers have discovered a protein that shows promise as an alternate corn rootworm control mechanism.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!